Phase 2 Peripheral T Cells Lymphoma (PTCL) Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
Peripheral T Cells Lymphoma (PTCL)
The Lymphoma Academic Research Organisation49 enrolled20 locationsNCT07018752
Recruiting
Phase 2
Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL
Peripheral T Cells Lymphoma (PTCL)
The First Affiliated Hospital of Soochow University26 enrolled1 locationNCT07372352
Recruiting
Phase 1Phase 2
Polyspecific Antibodies in Lymphoproliferative T-cell Disorders
Peripheral T Cells Lymphoma (PTCL)
Xenothera SAS54 enrolled8 locationsNCT06495723